1 / 34

Global Blood Screening Market Analysis, 2020 - MarkNtel Advisors

According to MarkNtel Advisorsu2019 research report titled u201cGlobal Blood Screening Market Analysis, 2020u201d, the Global Blood Screening market is anticipated to grow at a CAGR of around 8.5% during 2020-25F <br><br>More- https://www.marknteladvisors.com/research-library/global-blood-screening-market.html

marknteladvisors
Download Presentation

Global Blood Screening Market Analysis, 2020 - MarkNtel Advisors

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. marknteladvisors.com Global Blood Screening Market Analysis, 2020

  2. Document Outline Introduction About Us, Key Questions Answered In This Study 02 Table of Content Market Segmentation, Scope of Work 05 Research Process & Methodology Primary Research, Secondary Research, Companies Interviewed, Respondent Profile, Research Methodology, Forecasting 22 Sample Pages Global Blood Screening Market Analysis, 2020 30 Commercials 66 Disclaimer 68

  3. Market Segmentation Global Blood Screening Market Segmentation By Region By Solution By Technology By Company • North America • The US • Canada • Mexico • South America • Brazil • Others • Europe • Germany • The UK • France • Italy • Spain • Others • Middle East and Africa • UAE • Saudi Arabia • South Africa • Others • Asia-Pacific • China • India • Japan • Australia • Others • Reagents & Kits • Nucleic Acid Testing (NAT) • Enzymes & Polymerases • Standards & Controls • Probes & Primers • Buffers, Nucleotides, and Solutions • Labeling & Detection Reagents • Enzyme-Linked Immunosorbent Assay (Elisa) • Immunosorbents • Controls • Conjugates • Substrates • Sample Diluents & Wash Solutions • Instruments • Rental Purchase • Outright Purchase • Software & Services • Grifols • Abbott • Roche • Bio-Rad • Biomerieux • ThermoFisher • Diasorin • Perkinelmer • Trinity Biotech • BD • Nucleic Acid Testing • Transcription-Mediated Amplification • Real-Time Polymerase Chain Reaction • Enzyme-Linked Immunosorbent Assay • Chemiluminescence Immunoassay • Fluorescent Immunoassay • Colorimetric Immunoassays • Rapid Tests • Western Blot Assays • Next-Generation Sequencing (NGS) By End User • Blood Banks • Hospitals • Diagnostic Centers & Pathology Labs • Others (Ambulatory Surgical Centers, etc.)

  4. Historical Year: 2015 Base Year: 2019 Forecast Year: 2025 Table of Content (1/15)

  5. Historical Year: 2015 Base Year: 2019 Forecast Year: 2025 Table of Content (2/15)

  6. Historical Year: 2015 Base Year: 2019 Forecast Year: 2025 Table of Content (3/15)

  7. Historical Year: 2015 Base Year: 2019 Forecast Year: 2025 Table of Content (4/15)

  8. Historical Year: 2015 Base Year: 2019 Forecast Year: 2025 Table of Content (5/15)

  9. Historical Year: 2015 Base Year: 2019 Forecast Year: 2025 Table of Content (6/15)

  10. Historical Year: 2015 Base Year: 2019 Forecast Year: 2025 Table of Content (7/15)

  11. Historical Year: 2015 Base Year: 2019 Forecast Year: 2025 Table of Content (8/15)

  12. Historical Year: 2015 Base Year: 2019 Forecast Year: 2025 Table of Content (9/15)

  13. Historical Year: 2015 Base Year: 2019 Forecast Year: 2025 Table of Content (10/15)

  14. Historical Year: 2015 Base Year: 2019 Forecast Year: 2025 Table of Content (11/15)

  15. Historical Year: 2015 Base Year: 2019 Forecast Year: 2025 Table of Content (12/15)

  16. Historical Year: 2015 Base Year: 2019 Forecast Year: 2025 Table of Content (13/15)

  17. Historical Year: 2015 Base Year: 2019 Forecast Year: 2025 Table of Content (14/15)

  18. Historical Year: 2015 Base Year: 2019 Forecast Year: 2025 Table of Content (15/15)

  19. Document Outline Introduction About Us, Key Questions Answered In This Study 02 Table of Content Market Segmentation, Scope Of Work 05 Research Process & Methodology Primary Research, Secondary Research, Companies Interviewed, Respondent Profile, Research Methodology, Forecasting 22 Sample Pages Global Blood Screening Market Analysis, 2020 30 Commercials 66 Disclaimer 68

  20. Global Blood Screening Market Outlook, 2015-2025F

  21. Global Blood Screening Market Outlook, By Revenues • Figure XX: Global Blood Screening Market Revenues (USD Million),2015- 2025F Revenue: XX% Revenue: XX% Source: MarkNtel Advisors • The global blood screening market is anticipated to surge over the next 5 years owing to the increasing aging population. The blood transfused in individuals aged more than 60 years in high-income countries is accounting for up to 75% of total transfusions as per the World Health Organization (WHO). According to the United Nations, worldwide has around 0.7 billion population aged 65 or above in 2019 and is expected to reach about 1 billion by 2030, with the increasing geriatric population, the demand for blood screening solutions is supposed to augment by 2025. • The recently spread of COVID-19 across the world is anticipated to restrict the growth of the global blood screening market in 2020 and consecutive years. This is attributed due to the decreasing number of blood donations and reducing inessential surgical procedures that lead to reduce demand for blood worldwide.

  22. Global Blood Screening Market Outlook, By Revenues World Population Aged 65 years or Over (in Thousands) Source: United Nations

  23. Global Blood Screening Market Revenue Share, By Solution • Figure XX: Global Blood Screening Market Revenue Share (%), By Solution, 2015 - 2025F Source: MarkNtel Advisors *These are dummy charts and do not represent actual value • Reagents & Kits: This segment is expected to account for a maximum share during the forecast years. The reagents and kits are used in the initial stage of blood screening and such solutions are used broadly for rapid and effective detection of transfusion-transmissible diseases such as hepatitis, cytomegalovirus, etc. across the globe. Moreover, reagents are a cost-effective solution, while instruments comprise high cost, therefore reagents draw end-users across the globe. These are among the major attributes that anticipated to support the segment to grow in the coming years. • The blood transfusion requires in situations such as trauma, pregnancy, and childbirth, etc. worldwide. A growing number of road accidents and increasing childbirth worldwide have been driving the demand for blood and subsequently, the need for reagents and kits for blood screening is augmenting from the past few years.

  24. Global Blood Screening Market Revenue Share, By Reagents & Kits • Figure XX: Global Blood Screening Market Revenue Share (%),By Reagents & Kits, 2019& 2025F CAGR: XX% Key factors: The growing cases of sickle cell disease, government vision to increase medical tourism 2019 2025F CAGR: XX% Key factors: XXX Source: MarkNtel Advisors *These are dummy charts and do not represent actual value • Nucleic Acid Testing: This is the majorly used solution across the globe from the past few years. Some of the reasons that contribute to rising the segment growth are as follows: • Blood transfusion used to provide red blood cells to the patients diagnosed with sickle cell disease, which is diagnosed among individuals across the globe, particularly in Africa. Hence, the demand for nucleic acid testing is expected to surge for blood screening globally. • The government focus towards increasing medical tourism in UAE and Saudi Arabia is supposed to generate the additional demand for blood in the emirates, thus anticipated that the global nucleic acid testing market is mounting by 2025.

  25. Global Blood Screening Market Revenue Share, By Enzyme-Linked Immunosorbent Assay • Figure XX: Global Blood Screening Market Revenue Share (%),By Enzyme-Linked Immunosorbent Assay, 2015 - 2025F Source: MarkNtel Advisors

  26. Global Blood Screening Market Size, By Technology • Figure XX: Global Blood Screening Market Size(USD Million), By Technology, 2019 & 2025F 2019 2025F Source: MarkNtel Advisors *These are dummy charts and do not represent actual value • Nucleic Acid Testing segment is anticipated to dominate the global blood screening market during the forecast years 2020-25. This is attributed due to high sensitivity feature than other alternatives and specificity for viral nucleic acids such as DNA and RNA. Moreover, this technology has been improved the accuracy of identifying the viral agents in a small time period, therefore, the demand for nucleic acid testing technology is boosting from the past few years. • While the Enzyme-Linked Immunosorbent Assay (ELISA) market is projected to rise owing to availability at low cost, continuous improvement to surge the specificity and the rising probability of developing infectious diseases among individuals across the globe, particularly in Asia-Pacific region.

  27. Global Blood Screening Market Attractiveness Index, By Region Market Size, 2019 (USD Mn) CAGR (2020-2025) Source: MarkNtel Advisors *These are dummy charts and do not represent actual value

  28. North America Blood Screening Market Outlook, 2015-2025F

  29. North America Blood Screening Market Outlook, By Revenues • Figure XX: North America Blood Screening Market Revenues (USD Million),2015- 2025F Revenue: XX% Revenue: XX% Source: MarkNtel Advisors • North America is projected to dominate the global blood screening market during the forecast years 2020-25. Some factors that contribute to the growth of North America market are as follows: • The presence of major blood screening players coupled with increasing research and development for introducing new products is driving the North America market from the past few years. For instance: Roche launched Zika blood screening test in January 2020, this product help the end-users to screen the donated blood in the region. • The surging number of patients diagnosed with cardiovascular disease is anticipated to increase the number of cardiac surgeries in North America. Blood transfusion majorly used in cardiac surgical procedures, this would generate the demand for more blood in the healthcare settings and would augment the demand for blood screening solutions over the next 5 years.

  30. North America Blood Screening Market Revenue Share, By Solution • Figure XX: North America Blood Screening Market Revenue Share (%), By Solution, 2015 - 2025F Source: MarkNtel Advisors *These are dummy charts and do not represent actual value • Reagents & Kits: The availability of a broad range of reagents & kits in the region, surging risk of new pathogens, and mandate screening of some diseases such as hepatitis B, hepatitis C, HIV, etc. in North America are driving the reagents and kits segment from the past few years. Moreover, the growing awareness about early diagnosis coupled with increasing adoption of the advanced method of blood screening in healthcare settings is expected to drive the segment growth over the next 5 years. • The reimbursement policy for the treatment of several diseases is expected to add more patients' footfall in the region, which expected to generate the requirement for blood transfusion, thus the demand for blood would escalate in the coming years. Therefore, anticipated that the sale of blood screening reagents and kits would boost during the forecast years 2020-25.

  31. North America Blood Screening Market Revenue Share & Market Size, By Reagents & Kits • Figure XX: North America Blood Screening Market Revenue Share (%) & Market Size (USD Million), By Reagents & Kits, 2019& 2025F CAGR: XX% Key factors: XXX 2019 2025F CAGR: XX% Key factors: XXX Source: MarkNtel Advisors *These are dummy charts and do not represent actual value

  32. North America Blood Screening Market Revenue Share, By Enzyme-Linked Immunosorbent Assay • Figure XX: North America Blood Screening Market Revenue Share (%),By Enzyme-Linked Immunosorbent Assay, 2015 - 2025F Source: MarkNtel Advisors

  33. Document Outline Introduction About Us, Key Questions Answered In This Study 02 Table of Content Market Segmentation, Scope of Work 05 Research Process & Methodology Primary Research, Secondary Research, Companies Interviewed, Respondent Profile, Research Methodology, Forecasting 22 Sample Pages Global Blood Screening Market Analysis, 2020 30 Commercial 66 Disclaimer 68

  34. +1 (613) 707-5086 sales@marknteladvisors.com

More Related